Biotronik, Inc.
United StatesFDA applicant, unverified FDA FEI 1028232
Biotronik, Inc. is a medical device manufacturer, with 1,143 devices listed in 4 registries (FDA Class II, Class III and Unclassified) and 42 FDA recalls as of 16 Nov 2026.
- Devices
- 1,143
- Registrations
- FDA
- FDA recalls
- 42
Registry facts
- Registries
- FDA GUDID 1,028
- EUDAMED 370
- FDA 510(k) 104
- FDA PMA 11
- Device classes
- FDA Class II 730
- FDA Class III 396
- FDA Unclassified 17
- FDA recalls
- Identifiers
- FDA FEI 1028232
At a glance
Market reach
- United States
- FDA establishment, FDA recalls
What Biotronik, Inc. makes
Biotronik, Inc. manufactures a range of interventional cardiovascular devices, including peripheral and coronary angioplasty balloon catheters, bare-metal and drug-eluting coronary artery stents (with bioabsorbable-polymer coatings), peripheral artery stents, and manual peripheral vascular guidewires. Notable examples include the Passeo-18 and Passeo-35 Xeo coronary stents, the Orsiro Mission drug-eluting stent, and the Pantera LEO balloon catheter.
The company’s products are regulated under FDA pathways, with devices classified as Class II, Class III, or Unclassified, and are listed via 510(k) and UDI registrations.
Catalogue
Search and filter all 1,143 devicesShowing 1-50 of 1,143
Company details
- FDA FEI number
- 1028232
- Address
- 6024 JEAN RD., LAKE OSWEGO, OR, 97035
FDA recalls
FDA recall records list 42 recalls initiated by Biotronik, Inc., the earliest on 2003-02-21 and the most recent on 2021-03-08. By recorded status: 42 terminated. The reasons filed fall into these groups: software or firmware and electrical or power. A recall is often a precaution started by the manufacturer, and a count of records is not a verdict on a company.
Recalls initiated per year
- 2017 0
- 2018 0
- 2019 0
- 2020 0
- 2021 25
- 2022 0
- 2023 0
- 2024 0
- 2025 0
- 2026 0
2021
- 8 Mar 2021 Z-1441-2021 Class II Terminated There is a potential for premature battery depletion in Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy Defibrillators (CRT'Ds)
- 8 Mar 2021 Z-1442-2021 Class II Terminated There is a potential for premature battery depletion in Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy Defibrillators (CRT'Ds)
- 8 Mar 2021 Z-1443-2021 Class II Terminated There is a potential for premature battery depletion in Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy Defibrillators (CRT'Ds)
- 8 Mar 2021 Z-1444-2021 Class II Terminated There is a potential for premature battery depletion in Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy Defibrillators (CRT'Ds)
- 8 Mar 2021 Z-1445-2021 Class II Terminated There is a potential for premature battery depletion in Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy Defibrillators (CRT'Ds)
- 8 Mar 2021 Z-1446-2021 Class II Terminated There is a potential for premature battery depletion in Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy Defibrillators (CRT'Ds)
- 8 Mar 2021 Z-1447-2021 Class II Terminated There is a potential for premature battery depletion in Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy Defibrillators (CRT'Ds)
- 8 Mar 2021 Z-1448-2021 Class II Terminated There is a potential for premature battery depletion in Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy Defibrillators (CRT'Ds)
- 8 Mar 2021 Z-1449-2021 Class II Terminated There is a potential for premature battery depletion in Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy Defibrillators (CRT'Ds)
- 8 Mar 2021 Z-1450-2021 Class II Terminated There is a potential for premature battery depletion in Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy Defibrillators (CRT'Ds)
Show the 25 most recent of 42 recalls
2021
- 8 Mar 2021 Z-1451-2021 Class II Terminated There is a potential for premature battery depletion in Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy Defibrillators (CRT'Ds)
- 8 Mar 2021 Z-1452-2021 Class II Terminated There is a potential for premature battery depletion in Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy Defibrillators (CRT'Ds)
- 8 Mar 2021 Z-1453-2021 Class II Terminated There is a potential for premature battery depletion in Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy Defibrillators (CRT'Ds)
- 8 Mar 2021 Z-1454-2021 Class II Terminated There is a potential for premature battery depletion in Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy Defibrillators (CRT'Ds)
- 8 Mar 2021 Z-1455-2021 Class II Terminated There is a potential for premature battery depletion in Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy Defibrillators (CRT'Ds)
- 8 Mar 2021 Z-1456-2021 Class II Terminated There is a potential for premature battery depletion in Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy Defibrillators (CRT'Ds)
- 8 Mar 2021 Z-1457-2021 Class II Terminated There is a potential for premature battery depletion in Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy Defibrillators (CRT'Ds)
- 8 Mar 2021 Z-1458-2021 Class II Terminated There is a potential for premature battery depletion in Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy Defibrillators (CRT'Ds)
- 8 Mar 2021 Z-1459-2021 Class II Terminated There is a potential for premature battery depletion in Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy Defibrillators (CRT'Ds)
- 8 Mar 2021 Z-1460-2021 Class II Terminated There is a potential for premature battery depletion in Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy Defibrillators (CRT'Ds)
- 8 Mar 2021 Z-1461-2021 Class II Terminated There is a potential for premature battery depletion in Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy Defibrillators (CRT'Ds)
- 8 Mar 2021 Z-1462-2021 Class II Terminated There is a potential for premature battery depletion in Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy Defibrillators (CRT'Ds)
- 8 Mar 2021 Z-1463-2021 Class II Terminated There is a potential for premature battery depletion in Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy Defibrillators (CRT'Ds)
- 8 Mar 2021 Z-1464-2021 Class II Terminated There is a potential for premature battery depletion in Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy Defibrillators (CRT'Ds)
- 8 Mar 2021 Z-1465-2021 Class II Terminated There is a potential for premature battery depletion in Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy Defibrillators (CRT'Ds)
FDA establishments
- Biotronik AG BULACH Zurich · CH FEI 3002808050
Frequently asked questions
How many devices does Biotronik, Inc. have in the registry?
The registry currently lists 1143 devices for Biotronik, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Biotronik, Inc.'s devices?
Among its 50 most recently registered devices, Biotronik, Inc. has devices listed in EUDAMED (16 devices), FDA 510(k) (2 devices) and FDA GUDID (48 devices). A device can be listed in more than one registry, so these counts overlap.
What risk classes do Biotronik, Inc.'s devices fall under?
Among its 50 most recently registered devices, the classes recorded for Biotronik, Inc.'s devices are Class II and Class III. Each device page shows its own class and authorisation.
Are there FDA recall records for Biotronik, Inc.?
FDA recall records list 42 recalls initiated by Biotronik, Inc., the most recent initiated on 8 Mar 2021. A recall is often a precaution started by the manufacturer; the records say nothing about the company's overall record.
What are the newest devices from Biotronik, Inc. in the registry?
The most recently registered devices listed for Biotronik, Inc. include Orsiro Mission 4.5/9/140, Orsiro Mission 5.0/9/140, Orsiro Mission 5.0/13/140 and Orsiro Mission 4.5/13/140.
Which FDA establishments are linked to Biotronik, Inc.?
1 FDA establishment is linked to Biotronik, Inc. in the registry; they are listed on the company page.